[PDF][PDF] Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institution
FF Zhou, LP Xia, X Wang, GF Guo, YM Rong… - Chin J …, 2010 - scholar.archive.org
… Adjuvant chemotherapy in males with cancer of the breast [J]. Am J Clin Oncol, 1987,10(1):…
A prospective study of adjuvant CMF in male with node positive breast cancer 20鄄year follow…
A prospective study of adjuvant CMF in male with node positive breast cancer 20鄄year follow…
淋巴结阳性的局部晚期胃癌患者辅助放化疗的益处
张善慧， 周非， 梁东海， 吕红英， 于洪升 - Oncology and Translational …, 2020 - otm.tjh.com.cn
淋巴结阳性的局部晚期胃癌患者辅助放化疗的益处-Benefit of adjuvant chemoradiotherapy in
patients with pathologically lymph node-positive and locally advanced gastric cancer …
patients with pathologically lymph node-positive and locally advanced gastric cancer …
[PDF][PDF] 术后放化疗对淋巴结阳性食管鳞癌患者的临床意义
刘玉辉， 马楠， 陈哓夏， 徐龙， 刘兆喆… - 现代生物医学 …, 2014 - biomed.cnjournals.com
… significant postoperative chemoradiotherapy treatment factors in relative to the prognosis of
patients with lymph node positive esophageal … Postoperative chemoradiotherapy. in lymph …
patients with lymph node positive esophageal … Postoperative chemoradiotherapy. in lymph …
[HTML][HTML] ⅠB~ ⅡA1 期宫颈癌术后合并中危因素患者化疗或放疗疗效及生活质量分析
杨颖倩， 周德兰， 韩男男， 李甦… - … 医科大学学报(自然科学版), 2021 - jnmu.njmu.edu.cn
… the efficacy of postoperative chemotherapy in patients with … quality of patients undergoing
postoperative chemotherapy or … was conducted on 113 patients at the First Affiliated Hospital of …
postoperative chemotherapy or … was conducted on 113 patients at the First Affiliated Hospital of …
139 例晚期食管鳞状细胞癌的一线化疗及生存分析
闫晓杰， 夏学明， 刘钦兰， 白莉 - 解放军医学院学报, 2015 - xuebao.301hospital.com.cn
… (ESCC) in first-line chemotherapy and the factors related to the prognosis. Methods Clinical
… ESCC patients with 124 males and 15 females who received first-line chemotherapy in our …
… ESCC patients with 124 males and 15 females who received first-line chemotherapy in our …
乳腺癌分子分型在多西他赛密集新辅助化疗疗效及预后中的预测价值
刘秋明， 曹亚丽， 吴晓波， 夏勇， 涂剑宏， 欧阳倩雯… - 肿瘤防治研究, 2013 - zlfzyj.com
… The prognosis of Luminal A is better than Her-2+ and triple negative. … doxorubicin/
cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk …
cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk …
[HTML][HTML] 食管癌新辅助放化疗对手术及生存率的影响
曹秀峰 - 世界华人消化杂志, 2010 - wjgnet.com
… Neoadjuvant chemotherapy is often used to treat solid tumors before surgery or during the
perioperative period. It is often combined with radiotherapy to improve survival and cure rate …
perioperative period. It is often combined with radiotherapy to improve survival and cure rate …
含THP 乳腺癌不同辅助化疗方案疗效评价及预后分析
张晓辉， 孙强， 周易冬， 关竞红， 茅枫， 林燕 - 中国肿瘤临床, 2010 - cjco.cn
… /pirarubicin) adjuvant chemotherapeutic regimens for patients with … survival (DFS), overall
survival (OS) and adverse effect in 102 of the 294 patients with adjuvant chemotherapeutic …
survival (OS) and adverse effect in 102 of the 294 patients with adjuvant chemotherapeutic …
乳腺肿瘤免疫微环境及其在临床免疫治疗中的应用
谭璐媛， 王妍， 钟文静， 龚畅 - 中华乳腺病杂志(电子版), 2018 - zhrxbzz.cma-cmc.com.cn
… in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer
comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-…
comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-…
局部晚期食管癌根治术后放疗同步周方案化疗的耐受性研究.
倪文婕， 于舒飞， 杨劲松， 章文成… - Chinese Journal of …, 2019 - search.ebscohost.com
… Postoperative radiation therapy with or without concurrent chemotherapy for node⁃positive
thoracic esophageal squamous … Survival benefits of postoperative chemoradiation for lymph …
thoracic esophageal squamous … Survival benefits of postoperative chemoradiation for lymph …